IDH1 and glioma: Multivariate analysis further revealed that the miRNA signature remained an independent prognostic risk factor for glioma patient survival (P = 1.12e-6; see details in Supplementary Table S4), although isocitrate dehydrogenase (IDH) mutation status had weak significance (P = 0.063).